UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

The European respiratory journal, 2017-11, Vol.50 (5), p.1701462-1701462

2017

Link zum Volltext

Verfügbarkeit prüfen

Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline

The European respiratory journal, 2017-03, Vol.49 (3), p.1700146-1700146

2017

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis elimination: where are we now?

European respiratory review, 2018-06, Vol.27 (148), p.180035

2018

Link zum Volltext

Verfügbarkeit prüfen

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

The European respiratory journal, 2018-07, Vol.52 (1), p.1800934-1800934

2018

Link zum Volltext

Verfügbarkeit prüfen

Towards tuberculosis elimination: an action framework for low-incidence countries

The European respiratory journal, 2015-04, Vol.45 (4), p.928-952

2015

Link zum Volltext

Verfügbarkeit prüfen

Drug resistant TB – latest developments in epidemiology, diagnostics and management

International journal of infectious diseases, 2022-11, Vol.124, p.S20-S25

2022

Link zum Volltext

Verfügbarkeit prüfen

Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020

Emerging infectious diseases, 2020-11, Vol.26 (11), p.2709-2712

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

The European respiratory journal, 2012-12, Vol.40 (6), p.1430-1442

2012

Link zum Volltext

Verfügbarkeit prüfen

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

PLoS medicine, 2012-08, Vol.9 (8), p.e1001300

2012

Link zum Volltext

Verfügbarkeit prüfen

Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination

The European respiratory journal, 2013-09, Vol.42 (3), p.785-801

2013

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies

The lancet respiratory medicine, 2015-03, Vol.3 (3), p.220-234

2015

Link zum Volltext

Verfügbarkeit prüfen

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update

The European respiratory journal, 2018-05, Vol.51 (5), p.1702678-1702678

2018

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil

The European respiratory journal, 2017-03, Vol.49 (3), p.1602445-1602445

2017

Link zum Volltext

Verfügbarkeit prüfen

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

International journal of infectious diseases, 2022-11, Vol.124 (Suppl 1), p.S90-S103

2022

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis elimination: a dream or a reality? The case of Oman

The European respiratory journal, 2018-01, Vol.51 (1), p.1702027-1702027

2018

Link zum Volltext

Verfügbarkeit prüfen

Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker

The European respiratory journal, 2017-11, Vol.50 (5), p.1701414-1701414

2017

Link zum Volltext

Verfügbarkeit prüfen

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones

The European respiratory journal, 2012-10, Vol.40 (4), p.814-822

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study

International journal of infectious diseases, 2023-05, Vol.130, p.S25-S29

2023

Link zum Volltext

Verfügbarkeit prüfen

Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosis

The European respiratory journal, 2018-03, Vol.51 (3), p.1702187-1702187

2018

Link zum Volltext

Verfügbarkeit prüfen

Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico

The European respiratory journal, 2018-03, Vol.51 (3), p.1702267-1702267

2018

Link zum Volltext

Verfügbarkeit prüfen

The path to tuberculosis elimination: a renewed vision

The European respiratory journal, 2023-06, Vol.61 (6), p.2300499

2023

Link zum Volltext

Verfügbarkeit prüfen

The definition of tuberculosis infection based on the spectrum of tuberculosis disease

Breathe (Lausanne, Switzerland), 2021-09, Vol.17 (3), p.210079-210079

2021

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis treatment and drug regimens

Cold Spring Harbor perspectives in medicine, 2015-05, Vol.5 (5), p.a017822-a017822

2015

Link zum Volltext

Verfügbarkeit prüfen

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

International journal of infectious diseases, 2020-03, Vol.92, p.S15-S25

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(137)
Life Sciences & Biomedicine
(134)
Humans
(101)
Respiratory System
(88)
Tuberculosis
(60)
Antitubercular Agents - Therapeutic Use
(45)
Tuberculosis, Multidrug-Resistant - Drug Therapy
(43)
Male
(40)
Infectious Diseases
(35)
Female
(33)
Extensively Drug-Resistant Tuberculosis - Drug Therapy
(30)
Mycobacterium
(29)
Adult
(27)
World Health Organization
(21)
Drug Resistance
(19)
Treatment Outcome
(18)
Mdr-Tb
(17)
Middle Aged
(16)
Tuberculosis - Prevention & Control
(16)
Antitubercular Agents - Administration & Dosage
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline

Tuberculosis elimination: where are we now?

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

Towards tuberculosis elimination: an action framework for low-incidence countries

Drug resistant TB – latest developments in epidemiology, diagnostics and management

Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination

Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update

Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

Tuberculosis elimination: a dream or a reality? The case of Oman

Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study

Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosis

Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico

The path to tuberculosis elimination: a renewed vision

The definition of tuberculosis infection based on the spectrum of tuberculosis disease

Tuberculosis treatment and drug regimens

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)

Suchergebnisse filtern